Cargando…

Valproate pregnancy prevention scheme: what are the barriers to enrolling patients and how do we meet them?

BACKGROUND: The UK Medicines Health products Regulation Agency instructs that valproate prescriptions should be restricted in women of childbearing age to those consenting to the Pregnancy Prevention Programme (PPP). We assessed the compliance and barriers to the valproate PPP. METHODS: We retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watila, Musa Mamman, James, Alistair, Milne, Karen, Mackay, Graham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357668/ https://www.ncbi.nlm.nih.gov/pubmed/37483432 http://dx.doi.org/10.1136/bmjno-2023-000433

Ejemplares similares

Evaluation of telemedicine for new outpatient neurological consultations
por: Watila, Musa Mamman, et al.
Publicado: (2022)

Homoeologs: What Are They and How Do We Infer Them?
por: Glover, Natasha M., et al.
Publicado: (2016)

Enlarged Tonsils, What Shall We Do for Them?
Publicado: (1889)

What Are Lightness Illusions and Why Do We See Them?
por: Corney, David, et al.
Publicado: (2007)

Breeding Schemes: What Are They, How to Formalize Them, and How to Improve Them?
por: Covarrubias-Pazaran, Giovanny, et al.
Publicado: (2022)

Cancer Stem Cells: What Do We Know about Them?
por: Skvortsova, Ira
Publicado: (2021)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Do Non-Responders to Exercise Exist—and If So, What Should We Do About Them?
por: Pickering, Craig, et al.
Publicado: (2018)

The Enrolment Scheme and the Profession
Publicado: (1916)

Total cross-sections: do we understand them? why should we measure them?
por: Martin, A
Publicado: (1996)

Functional Multipotency of Stem Cells: What Do We Need from Them in the Heart?
por: Díez Villanueva, Pablo, et al.
Publicado: (2012)

Inpatient Glycemic Management: What Are the Goals and How Do We Achieve Them?: Preface
por: Seley, Jane Jeffrie
Publicado: (2014)

Moral Injuries in Healthcare Workers: What Causes Them and What to Do About Them?
por: Rabin, Sarah, et al.
Publicado: (2023)

Do we protect freshwater eels or do we drive them to extinction?
por: Arai, Takaomi
Publicado: (2014)

Bacteria and What We Know about Them
por: Fort, J. M.
Publicado: (1905)

Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?
por: McDonald, Kerrie L., et al.
Publicado: (2013)

Uncertainties in target volume delineation in radiotherapy – are they relevant and what can we do about them?
por: Segedin, Barbara, et al.
Publicado: (2016)

Vape shops: who uses them and what do they do?
por: Pattinson, Julie, et al.
Publicado: (2018)

Radioactivity and radiation: what they are, what they do, and how to harness them
por: Grupen, Claus, et al.
Publicado: (2016)

SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses
por: Fiorino, Sirio, et al.
Publicado: (2022)

Regenerating Myofibers after an Acute Muscle Injury: What Do We Really Know about Them?
por: Pizza, Francis X., et al.
Publicado: (2023)

A short history of neutrinos, what we have learned about them, what we have learned using them, up to neutrino oscillations.”
por: Steinberger, Jack
Publicado: (2012)

Why Cows Fail to Breed, and What to Do with Them
por: Jobson, George B.
Publicado: (1898)

Vitamin and Mineral Supplements: Do We Really Need Them?
por: Kamangar, Farin, et al.
Publicado: (2012)

Live operative workshops: Should we do away with them?
por: Kittur, Dinesh H.
Publicado: (2012)

Live operative workshops: Should we do away with them?
por: Chandrasekharam, V. V. S., et al.
Publicado: (2013)

Allergies to Titanium Dental Implants: What Do We Really Know about Them? A Scoping Review
por: Comino-Garayoa, Rubén, et al.
Publicado: (2020)

Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them?
por: Morales, María Luz, et al.
Publicado: (2023)

Renormalization schemes: where do we stand?
por: Ward, B F L
Publicado: (1990)

Results from a Theory-Guided Survey to Support Breast Cancer Trial Participation: Barriers, Enablers, and What to Do about them
por: Brehaut, Jamie C., et al.
Publicado: (2021)

Do household perceptions influence enrolment decisions into community-based health insurance schemes in Tanzania?
por: Kagaigai, Alphoncina, et al.
Publicado: (2021)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
por: Macfarlane, Alastair, et al.
Publicado: (2018)

Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
por: Sandhu, Vaneet K, et al.
Publicado: (2022)

The Consumptive Poor—What to Do with Them: A Plea for Notification
por: Findlay, William
Publicado: (1903)

What patients want to know, and what we actually tell them: The ABIDE project
por: Fruijtier, Agnetha D., et al.
Publicado: (2020)

Introduction to sessions on 'What can surgeons do for us (and we for them): radiology, pathology, molecular biology and local therapy'
por: Dixon, J Michael, et al.
Publicado: (2008)

Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them
por: Amaral, Leonard, et al.
Publicado: (2014)

LHRH analogues in breast cancer: clever, but do we need them?
por: Smith, I. E.
Publicado: (1991)

Lasers in Transurethral Enucleation of the Prostate—Do We Really Need Them
por: Herrmann, Thomas R.W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mn10ugiessjojetu5lnspf4t3i